GrowingStockReport.com

Celldex Therapeutics, Inc. (NASDAQ:CLDX) and Expedia Inc. (NASDAQ:EXPE) Added to Growing Stock Report's NASDAQ Decliners Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 01/06/2014 -- -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Celldex Therapeutics, Inc. (NASDAQ:CLDX) and Expedia Inc. (NASDAQ:EXPE).

Celldex Therapeutics, Inc. (NASDAQ:CLDX) a biopharmaceutical company that focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States closed down in its previous session (-8.03%) on 2,382,409 shares traded. Celldex Therapeutics, Inc. (NASDAQ:CLDX) is currently down (-42.74%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Expedia Inc. (NASDAQ:EXPE) together with its subsidiaries, operates as an online travel company in the United States and internationally closed down in its previous session (-0.35%) on 1,669,557 shares traded. Expedia Inc. (NASDAQ:EXPE) is currently down (-2.94%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Expedia Inc. (NASDAQ:EXPE)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com